Alkermes (ALKS) Peer Comparison

$47.41

$-1.49 (-3.05%)

As on 28-Aug-2026 16:03EDT

Market cap

$7,954 Mln

Revenue (TTM)

$1,668 Mln

P/E Ratio

128.1

P/B Ratio

4.5

Div. Yield

0 %

Edit

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
Market cap ($ Mln)	7,954	479	1,918
Revenue ($ Mln)	1,668	55	--
Net Profit ($ Mln)	66.12	-43.99	-62.27
Net Margin (%)	3.97	-80.67	--
RoE (%)	3.65	-15.51	-19.48
Price to Earnings	128.14	--	--
Price-To-Book	4.54	1.62	5.47

Cashflow
Ratios

Cashflow ($ Mln)

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
Cash From Operating Activities	520.75	-163.58	-43.55
Cash Flow from Investing Activities	295.50	-0.14	46.17
Cash from Financing Activities	12.38	-0.14	139.65
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
ROCE (%)	14.09	-61.63	-20.99
ROE (%)	3.65	-15.51	-19.48
ROA (%)	1.52	-11.26	-17.58
EBIT Margin (%)	9.38	-79.97	--
Net Margin (%)	3.97	-80.67	--
Cash Profit Margin (%)	0.00	0.00	--

Growth Ratios

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
Revenue Growth (%)	10.79	427.32	--
EBIT Growth (%)	-62.86	81.26	-57.95
Net Profit Growth (%)	-81.02	85.48	-51.82
EPS Growth (%)	-81.45	85.23	-33.77
Book Value Growth (%)	12.49	-8.69	10.54

Valuation Ratios

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
Price / Earnings	19.54	-2.11	-16.32
Price / Book Value	4.54	1.62	5.47
Dividend Yield (%)	0.00	0.00	0.00
EV/EBITDA	30.75	-4.50	-25.44
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
Debt to Equity	0.00	0.00	0.00
Short term debt to equity ratio	0.02	0.01	0.00
Current Ratio	2.30	25.05	28.70
Quick Ratio	1.85	25.05	28.70
Interest Coverage	2.65	--	-308.80

Operating Efficiency Ratios

	Alkermes (ALKS)	Prothena (PRTA)	GH Research PLC (GHRS)
Debtors to sales (%)	27.37	0.00	--
Asset Turnover	0.38	0.14	0.00
Receivable days	89.53	0.00	--
Inventory Days	352.79	--	--
Payable days	142.77	673.13	4,096.25
Cash Conversion Cycle	299.55	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly